Maddalena Mereu
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Dopaminergic signalling and behavioural alterations by Comt-Dtnbp1 genetic interaction and their clinical relevance.
Journal: British journal of pharmacology
Published: June 13, 2022
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction.
Journal: Disease models & mechanisms
Published: January 28, 2022
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 25, 2019
Dopamine-mediated immunomodulation affects choroid plexus function.
Journal: Brain, behavior, and immunity
Published: January 30, 2019
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.
Journal: Molecular psychiatry
Published: May 18, 2018
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.
Journal: Nature communications
Published: February 05, 2018
Synthetic cannabinoids: the hidden side of Spice drugs.
Journal: Behavioural pharmacology
Published: July 11, 2017
Brain-wide Mapping of Endogenous Serotonergic Transmission via Chemogenetic fMRI.
Journal: Cell reports
Published: April 05, 2017
Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task.
Journal: Scientific reports
Published: February 23, 2017
Last Updated: 09/26/2026